CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of $83.78 billion. The enterprise value is $85.19 billion.
| Market Cap | 83.78B |
| Enterprise Value | 85.19B |
Important Dates
The next confirmed earnings date is Wednesday, February 12, 2025, before market open.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
CME Group has 360.36 million shares outstanding. The number of shares has increased by 0.13% in one year.
| Current Share Class | 360.36M |
| Shares Outstanding | 360.36M |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 89.63% |
| Float | 358.86M |
Valuation Ratios
The trailing PE ratio is 24.45 and the forward PE ratio is 22.68. CME Group's PEG ratio is 5.32.
| PE Ratio | 24.45 |
| Forward PE | 22.68 |
| PS Ratio | 13.84 |
| Forward PS | 13.36 |
| PB Ratio | 2.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 23.09 |
| P/OCF Ratio | 22.54 |
| PEG Ratio | 5.32 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.24, with an EV/FCF ratio of 23.48.
| EV / Earnings | 24.89 |
| EV / Sales | 14.12 |
| EV / EBITDA | 20.24 |
| EV / EBIT | 22.01 |
| EV / FCF | 23.48 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.02 |
| Quick Ratio | 0.03 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.90 |
| Debt / FCF | 1.06 |
| Interest Coverage | 24.20 |
Financial Efficiency
Return on equity (ROE) is 12.30% and return on invested capital (ROIC) is 7.55%.
| Return on Equity (ROE) | 12.30% |
| Return on Assets (ROA) | 1.84% |
| Return on Capital (ROIC) | 7.55% |
| Revenue Per Employee | $1.69M |
| Profits Per Employee | $959,916 |
| Employee Count | 3,565 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid $985.00 million in taxes.
| Income Tax | 985.00M |
| Effective Tax Rate | 22.13% |
Stock Price Statistics
The stock price has increased by +12.44% in the last 52 weeks. The beta is 0.58, so CME Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +12.44% |
| 50-Day Moving Average | 233.65 |
| 200-Day Moving Average | 216.17 |
| Relative Strength Index (RSI) | 49.13 |
| Average Volume (20 Days) | 1,867,592 |
Short Selling Information
The latest short interest is 4.82 million, so 1.34% of the outstanding shares have been sold short.
| Short Interest | 4.82M |
| Short Previous Month | 4.32M |
| Short % of Shares Out | 1.34% |
| Short % of Float | 1.34% |
| Short Ratio (days to cover) | 2.53 |
Income Statement
In the last 12 months, CME Group had revenue of $6.03 billion and earned $3.42 billion in profits. Earnings per share was $9.51.
| Revenue | 6.03B |
| Gross Profit | 6.03B |
| Operating Income | 3.87B |
| Pretax Income | 4.25B |
| Net Income | 3.42B |
| EBITDA | 4.21B |
| EBIT | 3.87B |
| Earnings Per Share (EPS) | $9.51 |
Balance Sheet
The company has $2.43 billion in cash and $3.84 billion in debt, giving a net cash position of -$1.41 billion or -$3.91 per share.
| Cash & Cash Equivalents | 2.43B |
| Total Debt | 3.84B |
| Net Cash | -1.41B |
| Net Cash Per Share | -$3.91 |
| Equity (Book Value) | 28.22B |
| Book Value Per Share | 78.47 |
| Working Capital | 2.32B |
Cash Flow
In the last 12 months, operating cash flow was $3.72 billion and capital expenditures -$88.60 million, giving a free cash flow of $3.63 billion.
| Operating Cash Flow | 3.72B |
| Capital Expenditures | -88.60M |
| Free Cash Flow | 3.63B |
| FCF Per Share | $10.07 |
Margins
Gross margin is 100.00%, with operating and profit margins of 64.14% and 57.43%.
| Gross Margin | 100.00% |
| Operating Margin | 64.14% |
| Pretax Margin | 73.76% |
| Profit Margin | 57.43% |
| EBITDA Margin | 69.77% |
| EBIT Margin | 64.14% |
| FCF Margin | 60.13% |
Dividends & Yields
This stock pays an annual dividend of $10.40, which amounts to a dividend yield of 4.47%.
| Dividend Per Share | $10.40 |
| Dividend Yield | 4.47% |
| Dividend Growth (YoY) | 7.77% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 109.36% |
| Buyback Yield | -0.13% |
| Shareholder Yield | 4.34% |
| Earnings Yield | 4.08% |
| FCF Yield | 4.33% |
Analyst Forecast
The average price target for CME Group is $229.63, which is -1.23% lower than the current price. The consensus rating is "Hold".
| Price Target | $229.63 |
| Price Target Difference | -1.23% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 4.97% |
| EPS Growth Forecast (5Y) | 7.51% |
Stock Splits
The last stock split was on July 23, 2012. It was a forward split with a ratio of 5:1.
| Last Split Date | Jul 23, 2012 |
| Split Type | Forward |
| Split Ratio | 5:1 |
Scores
CME Group has an Altman Z-Score of 0.63 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.63 |
| Piotroski F-Score | 6 |